OKYO Pharma (OKYO) 10% Owner Gabriele Cerrone Receives 25,000-Share Award

What Happened

• Gabriele M. Cerrone, a reported 10% owner of OKYO Pharma Ltd (ticker: OKYO), received an award/acquisition of 25,000 common shares on 2026-07-20. The grant price reported was $1.40 per share, for a total reported value of $35,000. The transaction is coded as "A" (award/grant), which increases beneficial ownership rather than representing a sale.

Key Details

• Transaction date and price: 2026-07-20; 25,000 shares at $1.40 each.
• Total value: $35,000.
• Filing date: Form 4 filed 2026-07-21 (appears timely — filed one day after the transaction).
• Shares owned after transaction: Not specified in the provided filing.
• Notable footnotes: None disclosed in the provided filing (no 10b5-1 plan, tax withholding, or other special notations reported).

Context

• This was an award/grant (acquisition) rather than a sale; such transactions increase the insider's stake. As a 10% owner, Cerrone is a significant shareholder — this filing reflects ownership activity by a major investor, not necessarily executive compensation or routine open-market trading.